2024 Q2 Form 10-Q Financial Statement

#000103520124000007 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $226.7M $154.9M
YoY Change 16.71% 6.66%
Cost Of Revenue $77.64M $64.19M
YoY Change 9.56% 16.68%
Gross Profit $166.7M $206.6M
YoY Change 35.3% 171.47%
Gross Profit Margin 73.52% 133.35%
Selling, General & Admin $32.04M $35.60M
YoY Change -8.39% -1.08%
% of Gross Profit 19.23% 17.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $32.98M $33.40M
YoY Change 8.8% 9.75%
% of Gross Profit 19.79% 16.17%
Operating Expenses $118.5M $128.7M
YoY Change 10.5% 37.44%
Operating Profit $48.17M $77.89M
YoY Change 202.0% -544.5%
Interest Expense -$14.03M -$15.04M
YoY Change 10.49% 25.47%
% of Operating Profit -29.12% -19.31%
Other Income/Expense, Net $6.239M $6.838M
YoY Change 0.73% -4.75%
Pretax Income $41.68M $71.01M
YoY Change 282.69% -445.72%
Income Tax $10.00M $16.90M
% Of Pretax Income 23.99% 23.8%
Net Earnings $40.55M $69.92M
YoY Change 324.35% -414.79%
Net Earnings / Revenue 17.89% 45.14%
Basic Earnings Per Share $0.70 $1.21
Diluted Earnings Per Share $0.70 $1.21
COMMON SHARES
Basic Shares Outstanding 57.75M shares 57.68M shares
Diluted Shares Outstanding 58.33M shares 57.77M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.27M $42.81M
YoY Change -32.96% -18.12%
Cash & Equivalents $37.27M $42.81M
Short-Term Investments
Other Short-Term Assets $99.71M $130.3M
YoY Change -25.91% 14.3%
Inventory $17.65M $16.93M
Prepaid Expenses
Receivables $71.13M $51.35M
Other Receivables $41.06M $41.69M
Total Short-Term Assets $266.8M $283.1M
YoY Change -14.44% 5.14%
LONG-TERM ASSETS
Property, Plant & Equipment $3.942B $3.849B
YoY Change 24.06% 24.01%
Goodwill $37.04M $37.04M
YoY Change 0.61% 0.61%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $227.7M $227.6M
YoY Change 21.64% 23.68%
Total Long-Term Assets $4.604B $4.498B
YoY Change 25.18% 24.33%
TOTAL ASSETS
Total Short-Term Assets $266.8M $283.1M
Total Long-Term Assets $4.604B $4.498B
Total Assets $4.871B $4.781B
YoY Change 22.08% 23.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $143.5M $119.8M
YoY Change 3.8% -0.3%
Accrued Expenses $110.0M $90.22M
YoY Change 73.87% 13.44%
Deferred Revenue
YoY Change
Short-Term Debt $245.0M $280.0M
YoY Change 88.46% 115.38%
Long-Term Debt Due $1.183M $1.176M
YoY Change -35.18% -64.36%
Total Short-Term Liabilities $512.5M $507.9M
YoY Change 41.32% 44.98%
LONG-TERM LIABILITIES
Long-Term Debt $1.052B $1.052B
YoY Change -0.03% -0.02%
Other Long-Term Liabilities $80.09M $1.380B
YoY Change -90.62% 61.48%
Total Long-Term Liabilities $1.132B $1.052B
YoY Change 7.59% -0.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $512.5M $507.9M
Total Long-Term Liabilities $1.132B $1.052B
Total Liabilities $1.644B $1.560B
YoY Change 16.23% 11.22%
SHAREHOLDERS EQUITY
Retained Earnings $627.7M $603.3M
YoY Change 21.88% 16.02%
Common Stock $930.0M $877.5M
YoY Change 6.34% 12.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.545B $1.467B
YoY Change
Total Liabilities & Shareholders Equity $4.871B $4.781B
YoY Change 22.08% 23.0%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $40.55M $69.92M
YoY Change 324.35% -414.79%
Depreciation, Depletion And Amortization $32.98M $33.40M
YoY Change 8.8% 9.75%
Cash From Operating Activities $94.42M $26.52M
YoY Change 470.5% 26.44%
INVESTING ACTIVITIES
Capital Expenditures $104.6M $109.8M
YoY Change 9.87% 33.94%
Acquisitions
YoY Change
Other Investing Activities $48.00K $0.00
YoY Change -100.0%
Cash From Investing Activities -$104.6M -$109.8M
YoY Change 9.82% 33.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $206.0K
YoY Change -3.74%
Cash From Financing Activities 4.548M $86.59M
YoY Change -94.45% 38.48%
NET CHANGE
Cash From Operating Activities 94.42M $26.52M
Cash From Investing Activities -104.6M -$109.8M
Cash From Financing Activities 4.548M $86.59M
Net Change In Cash -5.588M $3.297M
YoY Change -273.27% 133.17%
FREE CASH FLOW
Cash From Operating Activities $94.42M $26.52M
Capital Expenditures $104.6M $109.8M
Free Cash Flow -$10.18M -$83.29M
YoY Change -87.05% 36.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 cwt Regulatory And Other Liabilities
RegulatoryAndOtherLiabilities
809165000 usd
CY2023Q4 cwt Regulatory And Other Liabilities
RegulatoryAndOtherLiabilities
760493000 usd
CY2024Q1 us-gaap Utilities Operating Expense Products And Services
UtilitiesOperatingExpenseProductsAndServices
64185000 usd
CY2023Q1 us-gaap Utilities Operating Expense Products And Services
UtilitiesOperatingExpenseProductsAndServices
55008000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4780834000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4595533000 usd
CY2024Q1 us-gaap Regulated Operating Revenue Water
RegulatedOperatingRevenueWater
270749000 usd
CY2023Q1 us-gaap Regulated Operating Revenue Water
RegulatedOperatingRevenueWater
131100000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35596000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35986000 usd
CY2024Q1 us-gaap Utilities Operating Expense Other
UtilitiesOperatingExpenseOther
26925000 usd
CY2023Q1 us-gaap Utilities Operating Expense Other
UtilitiesOperatingExpenseOther
16604000 usd
CY2024Q1 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
8010000 usd
CY2023Q1 us-gaap Utilities Operating Expense Maintenance
UtilitiesOperatingExpenseMaintenance
7978000 usd
CY2024Q1 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
32844000 usd
CY2023Q1 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
29915000 usd
CY2024Q1 cwt Utilities Operating Expense Income Tax Expense Benefit
UtilitiesOperatingExpenseIncomeTaxExpenseBenefit
15538000 usd
CY2023Q1 cwt Utilities Operating Expense Income Tax Expense Benefit
UtilitiesOperatingExpenseIncomeTaxExpenseBenefit
-5644000 usd
CY2024Q1 us-gaap Utilities Operating Expense Taxes
UtilitiesOperatingExpenseTaxes
9757000 usd
CY2023Q1 us-gaap Utilities Operating Expense Taxes
UtilitiesOperatingExpenseTaxes
8777000 usd
CY2024Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
192855000 usd
CY2023Q1 us-gaap Utilities Operating Expense
UtilitiesOperatingExpense
148624000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
77894000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-17524000 usd
CY2024Q1 us-gaap Unregulated Operating Revenue
UnregulatedOperatingRevenue
5098000 usd
CY2023Q1 us-gaap Unregulated Operating Revenue
UnregulatedOperatingRevenue
4623000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1954000 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2275000 usd
CY2024Q1 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
-3273000 usd
CY2023Q1 us-gaap Defined Benefit Plan Other Costs
DefinedBenefitPlanOtherCosts
-5221000 usd
CY2024Q1 us-gaap Public Utilities Allowance For Funds Used During Construction Additions
PublicUtilitiesAllowanceForFundsUsedDuringConstructionAdditions
1742000 usd
CY2023Q1 us-gaap Public Utilities Allowance For Funds Used During Construction Additions
PublicUtilitiesAllowanceForFundsUsedDuringConstructionAdditions
1404000 usd
CY2024Q1 cwt Utilities Nonregulated Expense Income Tax Expense Benefit
UtilitiesNonregulatedExpenseIncomeTaxExpenseBenefit
1321000 usd
CY2023Q1 cwt Utilities Nonregulated Expense Income Tax Expense Benefit
UtilitiesNonregulatedExpenseIncomeTaxExpenseBenefit
1794000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6838000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7179000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
15800000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
12818000 usd
CY2024Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
758000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
829000 usd
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
15042000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
11989000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
69690000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22334000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-227000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-123000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
69917000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-22211000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57733000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55666000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57774000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55666000 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
69690000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22334000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33401000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30433000 usd
CY2024Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
1667000 usd
CY2023Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
1641000 usd
CY2024Q1 us-gaap Public Utilities Allowance For Funds Used During Construction Additions
PublicUtilitiesAllowanceForFundsUsedDuringConstructionAdditions
1742000 usd
CY2023Q1 us-gaap Public Utilities Allowance For Funds Used During Construction Additions
PublicUtilitiesAllowanceForFundsUsedDuringConstructionAdditions
1404000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-21523000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-17089000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-20043000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11230000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
6028000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1342000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
17409000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
10024000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
86028000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-1375000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26515000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20970000 usd
CY2024Q1 us-gaap Payments To Acquire Water And Waste Water Systems
PaymentsToAcquireWaterAndWasteWaterSystems
109806000 usd
CY2023Q1 us-gaap Payments To Acquire Water And Waste Water Systems
PaymentsToAcquireWaterAndWasteWaterSystems
81980000 usd
CY2024Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1426000 usd
CY2023Q1 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
0 usd
CY2024Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
1426000 usd
CY2023Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 usd
CY2024Q1 cwt Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
0 usd
CY2023Q1 cwt Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
102000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-109806000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82082000 usd
CY2024Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1552000 usd
CY2024Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
170000000 usd
CY2023Q1 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
93448000 usd
CY2024Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
70000000 usd
CY2023Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
35000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
206000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
214000 usd
CY2024Q1 cwt Proceeds From Contribution In Aid Of Construction Financing Activities
ProceedsFromContributionInAidOfConstructionFinancingActivities
4522000 usd
CY2023Q1 cwt Proceeds From Contribution In Aid Of Construction Financing Activities
ProceedsFromContributionInAidOfConstructionFinancingActivities
3696000 usd
CY2024Q1 cwt Refunds Of Advances For Construction
RefundsOfAdvancesForConstruction
2351000 usd
CY2023Q1 cwt Refunds Of Advances For Construction
RefundsOfAdvancesForConstruction
2248000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1142000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1542000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
769000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18842000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
16164000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14456000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1160000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
86588000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
62526000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3297000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1414000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84966000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85025000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88263000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86439000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
3359000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
1578000 usd
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
37498000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
42038000 usd
CY2024Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
8417000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7032000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154900000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145225000 usd
CY2024Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
115849000 usd
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
-14125000 usd
CY2024Q1 us-gaap Regulated Operating Revenue Water
RegulatedOperatingRevenueWater
270749000 usd
CY2023Q1 us-gaap Regulated Operating Revenue Water
RegulatedOperatingRevenueWater
131100000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154900000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145225000 usd
CY2024Q1 cwt Maximum Collection Period In Which Deferred Net Wram And Mcba Revenues And Associated Costs Will Be Recognized
MaximumCollectionPeriodInWhichDeferredNetWRAMAndMCBARevenuesAndAssociatedCostsWillBeRecognized
P24M
CY2024Q1 cwt Maximum Collection Period In Which Deferred Net Wram And Mcba Revenues And Associated Costs Will Be Recognized
MaximumCollectionPeriodInWhichDeferredNetWRAMAndMCBARevenuesAndAssociatedCostsWillBeRecognized
P24M
CY2024Q1 cwt Maximum Collection Period In Which Deferred Net Wram And Mcba Revenues And Associated Costs Will Be Recognized
MaximumCollectionPeriodInWhichDeferredNetWRAMAndMCBARevenuesAndAssociatedCostsWillBeRecognized
P24M
CY2024Q1 us-gaap Revenue Recognition Leases
RevenueRecognitionLeases
Lease revenue is not considered revenue from contracts with customers and is recognized following operating lease standards. The Company is the lessor in operating lease agreements with telecommunications companies under which cellular phone antennas are placed on the Company’s property.
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2854000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5629000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1052000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2480000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1288000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
5795000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
126000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
540000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2744000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2854000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42814000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39591000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
45449000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
45375000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88263000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84966000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 usd
CY2022Q2 cwt Sale Of Stock Maximum Consideration On Transaction
SaleOfStockMaximumConsiderationOnTransaction
350000000 usd
CY2022Q2 cwt Sale Of Stock Agreement Term
SaleOfStockAgreementTerm
P3Y
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
326042 shares
CY2023Q1 cwt Proceeds From Issuance Of Common Stock Excluding Employee Stock Purchase Plans
ProceedsFromIssuanceOfCommonStockExcludingEmployeeStockPurchasePlans
18200000 usd
CY2023Q1 us-gaap Payments For Commissions
PaymentsForCommissions
200000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1430312000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
69690000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1507000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1142000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.2800
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16164000 usd
CY2024Q1 cwt Defined Benefit Plan Pension Plan Adjustment For Unrecoverable Pension Benefit Plan Costs
DefinedBenefitPlanPensionPlanAdjustmentForUnrecoverablePensionBenefitPlanCosts
13663000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
297000 usd
CY2024Q1 cwt Noncontrolling Interest Increase From Investment In Business
NoncontrollingInterestIncreaseFromInvestmentInBusiness
0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1470837000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1322394000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-22334000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17384000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.2600
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14456000 usd
CY2023Q1 cwt Noncontrolling Interest Increase From Investment In Business
NoncontrollingInterestIncreaseFromInvestmentInBusiness
0 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1302988000 usd
CY2024Q1 cwt Service Costs And Actuarial Gains Losses Reclassified To Other Comprehensive Loss
ServiceCostsAndActuarialGainsLossesReclassifiedToOtherComprehensiveLoss
13700000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16859000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3850000 usd
CY2024Q1 cwt Effective Income Tax Rate Reconciliation Increase Decrease Amount
EffectiveIncomeTaxRateReconciliationIncreaseDecreaseAmount
20700000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3900000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.146
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16600000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14000000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
4500000 usd
CY2024Q1 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
384501000 usd
CY2023Q4 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
257621000 usd
CY2024Q1 us-gaap Regulatory Liability Noncurrent
RegulatoryLiabilityNoncurrent
729904000 usd
CY2023Q4 us-gaap Regulatory Liability Noncurrent
RegulatoryLiabilityNoncurrent
683717000 usd
CY2024Q1 us-gaap Regulatory Assets Current
RegulatoryAssetsCurrent
56100000 usd
CY2023Q4 us-gaap Regulatory Assets Current
RegulatoryAssetsCurrent
64200000 usd
CY2024Q1 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
16600000 usd
CY2023Q4 us-gaap Regulatory Liability Current
RegulatoryLiabilityCurrent
21500000 usd
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
6900000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
6000000 usd
CY2024Q1 cwt Fair Value Inputs Risk Premium
FairValueInputsRiskPremium
0.0060
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001035201-24-000007-index-headers.html Edgar Link pending
0001035201-24-000007-index.html Edgar Link pending
0001035201-24-000007.txt Edgar Link pending
0001035201-24-000007-xbrl.zip Edgar Link pending
cws-03312024xex311.htm Edgar Link pending
cws-03312024xex312.htm Edgar Link pending
cws-03312024xex32.htm Edgar Link pending
cwt-20240331.htm Edgar Link pending
cwt-20240331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
cwt-20240331_def.xml Edgar Link unprocessable
cwt-20240331_lab.xml Edgar Link unprocessable
cwt-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cwt-20240331_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cwt-20240331_cal.xml Edgar Link unprocessable